newsfilter
← Latest News
PR Newswire·

Eiger Announces Publication of Positive Phase 2 Results of Avexitide in Children with Congenital Hyperinsulinism and Initiation of Phase 3 Program

- Phase 2 study demonstrating avexitide significantly reduced hypoglycemia in children with congenital hyperinsulinism published in Diabetes Care- Eiger plans to initiate avexitide Phase 3 registrational program by year-end 2022 PALO ALTO, Calif.,